Crossref
Empagliflozin improves oxidative stress injury in the diabetic liver by regulating Nrf2 signaling
International Journal of Clinical and Experimental Medicine · 2025
DOI: 10.62347/ipjn8980 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical and Experimental Medicine, 2025. Verfasst von Xiaoyun Zhang. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, X. (2025). Empagliflozin improves oxidative stress injury in the diabetic liver by regulating Nrf2 signaling. International Journal of Clinical and Experimental Medicine. https://doi.org/10.62347/ipjn8980
Vancouver
Zhang X. Empagliflozin improves oxidative stress injury in the diabetic liver by regulating Nrf2 signaling. International Journal of Clinical and Experimental Medicine. 2025. doi:10.62347/ipjn8980
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaoyun},
title = {Empagliflozin improves oxidative stress injury in the diabetic liver by regulating Nrf2 signaling},
journal = {International Journal of Clinical and Experimental Medicine},
year = {2025},
doi = {10.62347/ipjn8980}
}
EUVIMED